V3-Mediated Heparin Neutralization of HIV Type 1
- 1 November 1994
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 10 (11) , 1421-1423
- https://doi.org/10.1089/aid.1994.10.1421
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.This publication has 16 references indexed in Scilit:
- Combinatorially selected guanosine-quartet structureis a potent inhibitor of human immunodeficiency virus envelope-mediated cellfusion.Proceedings of the National Academy of Sciences, 1994
- Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 bindingAIDS, 1994
- Inhibition of Entry of HIV into Cells by Poly(A)·Poly(U)AIDS Research and Human Retroviruses, 1993
- The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides.Journal of Biological Chemistry, 1992
- Investigations into the Mechanism by Which Sulfated Polysaccharides Inhibit HIV Infection In VitroAIDS Research and Human Retroviruses, 1992
- Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 geneNature, 1991
- Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV InfectionAIDS Research and Human Retroviruses, 1990
- Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.Proceedings of the National Academy of Sciences, 1989
- Molecular modeling of protein-glycosaminoglycan interactions.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- The interaction of platelet factor four and glycosaminoglycansArchives of Biochemistry and Biophysics, 1985